サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1412721

子宮内避妊器具市場：タイプ別、年齢層別、エンドユーザー別-2024-2030年の世界予測

Intrauterine Devices Market by Type (Hormonal: Progestogen-releasing IUD, Nonhormonal: Copper-containing IUD), Age Group (15-24 Years, 25-34 Years, 35-44 Years), End User - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 185 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
子宮内避妊器具市場：タイプ別、年齢層別、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 185 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

子宮内避妊器具市場規模は2023年に31億3,000万米ドルと推計され、2024年には32億4,000万米ドルに達し、CAGR 4.59%で2030年には42億9,000万米ドルに達すると予測されます。

子宮内避妊器具の世界市場

主な市場の統計
基準年[2023］ 31億3,000万米ドル
予測年[2024］ 32億4,000万米ドル
予測年 [2030] 42億9,000万米ドル
CAGR（%） 4.59%
子宮内避妊器具 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは子宮内避妊器具市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、子宮内避妊器具市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-子宮内避妊器具市場の市場規模および予測は？

2-子宮内避妊器具市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-子宮内避妊器具市場における技術動向と規制の枠組みは？

4-子宮内避妊器具市場における主要ベンダーの市場シェアは？

5-子宮内避妊器具市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 望まない妊娠を避けるために養子縁組の増加
      • IUDを促進する政府とNGOの取り組み
    • 抑制要因
      • 弦の紛失やIUD使用による感染リスクに関する懸念
    • 機会
      • 次世代IUD（子宮内避妊具）の設計に注力
      • スマート子宮内避妊具の登場
    • 課題
      • 国民の間での認識と導入が限られている
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 子宮内避妊器具市場：タイプ別

  • ホルモン：プロゲストーゲン放出 IUD
  • 非ホルモン：銅含有 IUD

第7章 子宮内避妊器具市場：年齢層別

  • 15～24歳
  • 25～34歳
  • 35～44歳
  • 44歳以上

第8章 子宮内避妊器具市場：エンドユーザー別

  • クリニック
  • 地域医療センター
  • 病院

第9章 南北アメリカの子宮内避妊器具市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の子宮内避妊器具市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの子宮内避妊器具市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第13章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Actavis Generics by Teva Pharmaceutical Industries Ltd.
    • Agile Therapeutics, Inc.
    • Allergan Plc by Abbvie Inc
    • Ava AG
    • Bayer AG
    • Cardinal Health, Inc.
    • Contrel Europe NV
    • CooperSurgical Inc.
    • Egemen International
    • ERENLER MEDIKAL SAN. TIC. LTD. STI.
    • Eurogine S.L.
    • Fuji Latex Co., Ltd.
    • HLL Lifecare Limited
    • HRA Pharma, SAS
    • Melbea AG
    • Merck & Co., Inc.
    • Meril Life Sciences Pvt. Ltd.
    • Mona Lisa N.V.
    • Mylan NV by Viatris Inc.
    • Novartis AG
    • Ocon Medical Ltd
    • Pregna International Limited
    • Prosan International BV
    • Searchlight Pharma Inc.
    • SMB Corporation of India
  • 主要な製品ポートフォリオ

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. INTRAUTERINE DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. INTRAUTERINE DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. INTRAUTERINE DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. INTRAUTERINE DEVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. INTRAUTERINE DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. INTRAUTERINE DEVICES MARKET DYNAMICS
  • FIGURE 7. INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 10. INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 12. INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES INTRAUTERINE DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES INTRAUTERINE DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. INTRAUTERINE DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. INTRAUTERINE DEVICES MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. INTRAUTERINE DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. INTRAUTERINE DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. INTRAUTERINE DEVICES MARKET SIZE, BY HORMONAL: PROGESTOGEN-RELEASING IUD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. INTRAUTERINE DEVICES MARKET SIZE, BY NONHORMONAL: COPPER-CONTAINING IUD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 9. INTRAUTERINE DEVICES MARKET SIZE, BY 15-24 YEARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. INTRAUTERINE DEVICES MARKET SIZE, BY 25-34 YEARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. INTRAUTERINE DEVICES MARKET SIZE, BY 35-44 YEARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. INTRAUTERINE DEVICES MARKET SIZE, BY ABOVE 44 YEARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 14. INTRAUTERINE DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. INTRAUTERINE DEVICES MARKET SIZE, BY COMMUNITY HEALTH CARE CENTRES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. INTRAUTERINE DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES INTRAUTERINE DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. INTRAUTERINE DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 145. INTRAUTERINE DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. INTRAUTERINE DEVICES MARKET LICENSE & PRICING
目次
Product Code: MRR-8E22B61932D7

[185 Pages Report] The Intrauterine Devices Market size was estimated at USD 3.13 billion in 2023 and expected to reach USD 3.24 billion in 2024, at a CAGR 4.59% to reach USD 4.29 billion by 2030.

Global Intrauterine Devices Market

KEY MARKET STATISTICS
Base Year [2023] USD 3.13 billion
Estimated Year [2024] USD 3.24 billion
Forecast Year [2030] USD 4.29 billion
CAGR (%) 4.59%
Intrauterine Devices Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Intrauterine Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Intrauterine Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Intrauterine Devices Market, highlighting leading vendors and their innovative profiles. These include Actavis Generics by Teva Pharmaceutical Industries Ltd., Agile Therapeutics, Inc., Allergan Plc by Abbvie Inc, Ava AG, Bayer AG, Cardinal Health, Inc., Contrel Europe NV, CooperSurgical Inc., Egemen International, ERENLER MEDIKAL SAN. TIC. LTD. STI., Eurogine S.L., Fuji Latex Co., Ltd., HLL Lifecare Limited, HRA Pharma, SAS, Melbea AG, Merck & Co., Inc., Meril Life Sciences Pvt. Ltd., Mona Lisa N.V., Mylan NV by Viatris Inc., Novartis AG, Ocon Medical Ltd, Pregna International Limited, Prosan International BV, Searchlight Pharma Inc., and SMB Corporation of India.

Market Segmentation & Coverage

This research report categorizes the Intrauterine Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Hormonal: Progestogen-releasing IUD
    • Nonhormonal: Copper-containing IUD
  • Age Group
    • 15-24 Years
    • 25-34 Years
    • 35-44 Years
    • Above 44 Years
  • End User
    • Clinics
    • Community Health Care Centres
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Intrauterine Devices Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Intrauterine Devices Market?

3. What are the technology trends and regulatory frameworks in the Intrauterine Devices Market?

4. What is the market share of the leading vendors in the Intrauterine Devices Market?

5. Which modes and strategic moves are suitable for entering the Intrauterine Devices Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Intrauterine Devices Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising adoption to avoid unintended pregnancies
      • 5.1.1.2. Government and NGO initiatives to promote IUD
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns related to lost strings and risk of infection due to IUD usage
    • 5.1.3. Opportunities
      • 5.1.3.1. Focus on the design of next-generation IUD (intrauterine device)
      • 5.1.3.2. Emergence of smart intrauterine contraceptive device
    • 5.1.4. Challenges
      • 5.1.4.1. Limited awareness and adoption among population
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Intrauterine Devices Market, by Type

  • 6.1. Introduction
  • 6.2. Hormonal: Progestogen-releasing IUD
  • 6.3. Nonhormonal: Copper-containing IUD

7. Intrauterine Devices Market, by Age Group

  • 7.1. Introduction
  • 7.2. 15-24 Years
  • 7.3. 25-34 Years
  • 7.4. 35-44 Years
  • 7.5. Above 44 Years

8. Intrauterine Devices Market, by End User

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Community Health Care Centres
  • 8.4. Hospitals

9. Americas Intrauterine Devices Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Intrauterine Devices Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Intrauterine Devices Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Actavis Generics by Teva Pharmaceutical Industries Ltd.
    • 13.1.2. Agile Therapeutics, Inc.
    • 13.1.3. Allergan Plc by Abbvie Inc
    • 13.1.4. Ava AG
    • 13.1.5. Bayer AG
    • 13.1.6. Cardinal Health, Inc.
    • 13.1.7. Contrel Europe NV
    • 13.1.8. CooperSurgical Inc.
    • 13.1.9. Egemen International
    • 13.1.10. ERENLER MEDIKAL SAN. TIC. LTD. STI.
    • 13.1.11. Eurogine S.L.
    • 13.1.12. Fuji Latex Co., Ltd.
    • 13.1.13. HLL Lifecare Limited
    • 13.1.14. HRA Pharma, SAS
    • 13.1.15. Melbea AG
    • 13.1.16. Merck & Co., Inc.
    • 13.1.17. Meril Life Sciences Pvt. Ltd.
    • 13.1.18. Mona Lisa N.V.
    • 13.1.19. Mylan NV by Viatris Inc.
    • 13.1.20. Novartis AG
    • 13.1.21. Ocon Medical Ltd
    • 13.1.22. Pregna International Limited
    • 13.1.23. Prosan International BV
    • 13.1.24. Searchlight Pharma Inc.
    • 13.1.25. SMB Corporation of India
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing